tradingkey.logo
tradingkey.logo
Search

Hinge Health Inc

HNGE
Add to Watchlist
56.020USD
+1.010+1.84%
Close 05/08, 16:00ETQuotes delayed by 15 min
4.33BMarket Cap
LossP/E TTM

Hinge Health Inc

56.020
+1.010+1.84%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Hinge Health Inc

Currency: USD Updated: 2026-05-08

Key Insights

Hinge Health Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 4 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 57.53.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Hinge Health Inc's Score

Industry at a Glance

Industry Ranking
4 / 75
Overall Ranking
49 / 4494
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Hinge Health Inc Highlights

StrengthsRisks
Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 100.82% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 587.86M.
Undervalued
The company’s latest PE is -7.21, at a low 3-year percentile range.
Held by Ron Baron
Star Investor Ron Baron holds 999.57K shares of this stock.

Analyst Rating

Based on 16 analysts
Buy
Current Rating
69.533
Target Price
+26.42%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-08

The current financial score of Hinge Health Inc is 8.83, ranking 6 out of 75 in the Healthcare Providers & Services industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 182.31M, representing a year-over-year increase of 47.23%, while its net profit experienced a year-over-year increase of 141.64%.

Score

Industry at a Glance

Previous score
8.83
Change
0

Financials

9.66

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

8.81

Operational Efficiency

8.98

Growth Potential

9.07

Shareholder Returns

7.62

Hinge Health Inc's Company Valuation

Currency: USD Updated: 2026-05-08

The current valuation score of Hinge Health Inc is 6.73, ranking 44 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is -7.21, which is -67.11% below the recent high of -2.37 and 0.00% above the recent low of -7.21.

Score

Industry at a Glance

Previous score
6.73
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 4/75
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-08

The current earnings forecast score of Hinge Health Inc is 8.24, ranking 23 out of 75 in the Healthcare Providers & Services industry. The average price target is 65.00, with a high of 72.00 and a low of 48.00.

Score

Industry at a Glance

Previous score
8.24
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 16 analysts
Buy
Current Rating
69.533
Target Price
+26.42%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

246
Total
8
Median
12
Average
Company name
Ratings
Analysts
Hinge Health Inc
HNGE
16
Microsoft Corp
MSFT
60
Palo Alto Networks Inc
PANW
57
CrowdStrike Holdings Inc
CRWD
56
Zscaler Inc
ZS
50
Datadog Inc
DDOG
49
1
2
3
...
49

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-08

The current price momentum score of Hinge Health Inc is 9.62, ranking 9 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 62.93 and the support level at 42.21, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
9.62
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
2.632
Buy
RSI(14)
81.010
Overbought
STOCH(KDJ)(9,3,3)
94.658
Overbought
ATR(14)
2.626
High Vlolatility
CCI(14)
152.464
Buy
Williams %R
0.000
Overbought
TRIX(12,20)
1.002
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
52.900
Buy
MA10
48.829
Buy
MA20
45.670
Buy
MA50
43.361
Buy
MA100
42.859
Buy
MA200
47.043
Buy

Institutional Confidence

Currency: USD Updated: 2026-05-08

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Insight Venture Partners
9.38M
-15.00%
Atomico IV LP
4.14M
--
11.2 Capital Management LLC
3.70M
--
BIT Capital GmbH
3.32M
+79.29%
Tiger Global Management, L.L.C.
Star Investors
1.81M
+227.12%
Jane Street Capital, L.L.C.
1.57M
+3370.85%
Millennium Management LLC
1.48M
+192.81%
HANSAINVEST Hanseatische Investment GmbH
2.16M
--
Braidwell LP
1.30M
+43.29%
1
2

Risk Assessment

Currency: USD Updated: 2026-05-08

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Hinge Health Inc is 5.56, ranking 39 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
5.56
Change
0
Beta vs S&P 500 index
--
VaR
--
240-Day Maximum Drawdown
+48.52%
240-Day Volatility
+69.16%

Return

Best Daily Return
60 days
+17.28%
120 days
+17.28%
5 years
--
Worst Daily Return
60 days
-9.78%
120 days
-9.78%
5 years
--
Sharpe Ratio
60 days
+3.71
120 days
+1.30
5 years
--

Risk Assessment

Maximum Drawdown
240 days
+48.52%
3 years
--
5 years
--
Return-to-Drawdown Ratio
240 days
+0.81
3 years
--
5 years
--
Skewness
240 days
+1.04
3 years
--
5 years
--

Volatility

Realised Volatility
240 days
+69.16%
5 years
--
Standardised True Range
240 days
+4.68%
5 years
--
Downside Risk-Adjusted Return
120 days
+223.53%
240 days
+223.53%
Maximum Daily Upside Volatility
60 days
+42.58%
Maximum Daily Downside Volatility
60 days
+33.84%

Liquidity

Average Turnover Rate
60 days
+1.71%
120 days
+1.75%
5 years
--
Turnover Deviation
20 days
--
60 days
--
120 days
--

Peer Comparison

Healthcare Providers & Services
Hinge Health Inc
Hinge Health Inc
HNGE
8.34 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Encompass Health Corp
Encompass Health Corp
EHC
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cigna Group
Cigna Group
CI
8.52 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Pennant Group Inc
Pennant Group Inc
PNTG
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
Brightspring Health Services Inc
BTSG
8.34 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Progyny Inc
Progyny Inc
PGNY
8.28 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI